Export: +91 9820402906   Domestic: +91 7710003340 | HR: +91 9137757219

Thiamine Tablets BP (Vitamin B1)

Film-coated tablets containing Thiamine BP 75 mg for prevention or treatment of thiamine (Vitamin B1) deficiency when clinically appropriate.

Composition & Product Overview

Each film-coated tablet contains: Thiamine BP 75 mg.

Dosage form: Film-coated tablet.

Therapeutic category: Vitamin B1 / Nutritional Supplement / Thiamine Deficiency Management.

Usage: Prevention and treatment of thiamine deficiency and related deficiency states under professional guidance.

B2B enquiry: Contract manufacturing and export enquiries: +91 7710003340.

Categories

Product Information

Thiamine Tablets BP (Vitamin B1) is listed for pharmaceutical business-to-business enquiries. Exact active ingredients, formulation, strength, pack configuration and manufacturer details should be confirmed against the product label and approved technical documentation before ordering.

Description

1. Product Introduction

Healthy Life Pharma Pvt. Ltd. offers B2B manufacturing and supply support for Thiamine Tablets BP 75 mg. Thiamine (Vitamin B1) is a water-soluble vitamin required for carbohydrate metabolism, cellular energy production and normal nervous-system function.

Oral thiamine products may be used to prevent or treat thiamine deficiency when the oral route is appropriate. Patients with severe deficiency, suspected Wernicke encephalopathy, persistent vomiting, malabsorption or other high-risk clinical states may require urgent assessment and parenteral thiamine rather than relying on an oral tablet alone.

Manufacturing, export, WHO-GMP and other certification claims should be confirmed against current valid documents before publication or tender submission.

2. Product Specifications

Product NameThiamine Tablets BP 75 mg
Generic NameThiamine Tablets / Vitamin B1 Tablets
Confirmed Strength75 mg
CompositionThiamine BP 75 mg per film-coated tablet
Dosage FormFilm-coated tablet
Therapeutic ClassVitamin B1 / Nutritional Supplement
StandardBP claim as supplied; final product specification should follow the registered dossier
PackagingTo be confirmed from the approved commercial pack
Shelf LifeTo be established from approved stability data for the final formulation and pack

The supplied product composition confirms 75 mg. Other strengths mentioned in general marketing copy are not presented here as confirmed SKUs.

3. Manufacturing Considerations

Thiamine formulations require controls appropriate to the actual API form, excipients, coating and packaging system.

  • Blend and content uniformity: validated blending and in-process controls help ensure consistent dose distribution.
  • Compression: tablet weight, hardness, friability and disintegration are controlled according to the approved master formula.
  • Coating: a validated film coat can improve appearance, swallowability and taste/odor masking.
  • Moisture and light protection: suitable environmental controls and packaging should be selected based on stability studies for the final formulation.

Specific claims such as exact relative humidity limits, granulation method, Opadry system, dedicated equipment or Alu-Alu packaging should be published only when supported by the actual manufacturing and stability records.

4. Quality Assurance

Finished-product testing should follow the registered specification and applicable pharmacopoeial requirements. Typical controls may include:

  • Identification and assay of thiamine using a validated analytical method.
  • Uniformity of dosage units or weight variation, as applicable.
  • Disintegration and/or dissolution where required by the specification.
  • Related substances or degradation products where specified.
  • Microbial quality and packaging-integrity checks where applicable.

Acceptance criteria such as assay range, dissolution limits and shelf life must come from the approved specification rather than a generic website claim.

5. Why Thiamine (Vitamin B1) Is Used

Thiamine is converted in the body to active coenzyme forms, including thiamine pyrophosphate, which participate in carbohydrate and energy metabolism and are important for normal nerve and muscle function.

  • Thiamine deficiency: oral supplementation can be used for prevention or treatment when clinically appropriate.
  • Beriberi: treatment depends on severity and clinical presentation; significant cardiac or neurologic disease requires medical supervision.
  • Alcohol-related deficiency risk: people with chronic harmful alcohol use can be thiamine deficient, but suspected Wernicke encephalopathy requires urgent medical treatment and usually parenteral thiamine.
  • Increased nutritional requirements: supplementation may be considered when intake or absorption is inadequate, according to clinical guidance.

This page does not position a 75 mg oral tablet as a substitute for emergency treatment of severe thiamine deficiency.

6. Export and Regulatory Support

B2B registration and export support may include product specifications, analytical documentation and commercial paperwork depending on destination-market requirements and contractual scope.

  • Dossier support: CTD / ACTD or country-specific documentation where available.
  • Certificates: COA and other certificates only where current and applicable.
  • Packaging: blister, strip or bottle formats subject to registration and stability support.
  • Logistics: export arrangements can be planned according to destination-country requirements.

WHO-GMP, COPP, FSC, Star Export House status, TSE/BSE-free, Non-GMO and specific market approvals should be verified from current documentation before they are used in marketing.

7. Frequently Asked Questions

Q: What does each tablet contain?
A: The supplied composition states Thiamine BP 75 mg in each film-coated tablet.
Q: What is thiamine?
A: Thiamine is Vitamin B1, a water-soluble vitamin involved in energy metabolism and normal neurologic function.
Q: Is this the same as thiamine mononitrate?
A: Not necessarily. “Thiamine” products may use different thiamine salts. The final API identity should match the approved product specification and label; this page does not assume hydrochloride or mononitrate unless confirmed.
Q: Can oral thiamine treat Wernicke encephalopathy?
A: Suspected Wernicke encephalopathy is an urgent medical condition and typically requires parenteral thiamine and clinical management; an oral 75 mg tablet should not be relied upon as emergency treatment.
Q: Are very high doses automatically safe because thiamine is water soluble?
A: No medicine should be described as automatically harmless at any dose. Thiamine is generally well tolerated, but dose and route should be appropriate to the clinical situation and product label.

8. Dosage and Administration

Use according to the approved product label or a healthcare professional's direction. A single universal regimen is not appropriate for all causes and severities of thiamine deficiency.

  • Swallow the film-coated tablet with water unless the registered label states otherwise.
  • Oral thiamine may be taken with or without food; if stomach upset occurs, taking it with food may improve tolerability.
  • Severe deficiency, neurologic symptoms, malabsorption or suspected Wernicke encephalopathy may require parenteral treatment and urgent medical supervision.

9. Side Effects and Precautions

  • Common tolerability: oral thiamine is generally well tolerated; gastrointestinal upset or mild skin reactions can occur.
  • Allergy: seek medical care for signs of a serious hypersensitivity reaction.
  • Clinical caution: do not delay medical assessment for confusion, abnormal eye movements, severe weakness, gait problems, heart failure symptoms or other signs of severe deficiency.
  • Medicine review: chronic illness, malnutrition, prolonged vomiting, alcohol dependence and some medicines can increase thiamine deficiency risk; treatment should address the underlying cause.

10. Storage Instructions

  • Store according to the registered product label in a dry place protected from excessive heat, moisture and light.
  • Keep tablets in the original packaging until use.
  • Keep out of reach of children.

Exact storage temperature and shelf life should be based on approved stability data for the finished product.

For professional and B2B reference. Product claims, prescribing information, manufacturing statements, certificates and market approvals require verification against the final registered dossier and current documents.